Risk factors of invasive cervical cancer in Morocco
- PMID: 20003812
Risk factors of invasive cervical cancer in Morocco
Abstract
It is now well established that infection with oncogenic human papillomavirus (HPV) types is the necessary cause of cervical cancer (CC) and its immediate precursor cervical intraepithelial neoplasia 3. However, HPV infection alone may not be sufficient to cause CC, and other exogenous and endogenous factors may exist that, in conjunction with HPV, influence the risk of progression from cervical HPV infection to CC. In this chapter, we review the evidence for the role of parity, oral contraceptive (OC) use, and tobacco smoking in CC. In this study, molecular detection of HPV by PCR using consensus primers MY09/MY11 able to amplify the L1 gene present in all types of HPV from fresh frozen biopsies showed that the virus is present in 88% (99/113) of cases. The viral typing, carried out on HPV positive cases through hybridization using specifics probes MY14, WD74, WD126, MY16, MY70 and MY115 which correspond respectively to HPV 16, 18, 31, 33, 45 and 59 has revealed the prevalence of HPV 16 and 18 respectively with 65% (64/99) and 44.4% (44/99). Several combinations of double and multiple infections were also observed. Another part of this work has been devoted to the study of risk factors associated with the development of cancerous cervical lesions. The study is based on a questionnaire during the sampling and also on data collected from clinical records and records of hospital patients.
Similar articles
-
Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.J Natl Cancer Inst Monogr. 2003;(31):20-8. J Natl Cancer Inst Monogr. 2003. PMID: 12807941 Review.
-
A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1574-82. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15466972
-
Risk factors for cervical neoplasia in Denmark.APMIS Suppl. 1998;80:1-41. APMIS Suppl. 1998. PMID: 9693662
-
[Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].Acta Med Port. 2000 Jul-Aug;13(4):181-92. Acta Med Port. 2000. PMID: 11155485 Portuguese.
-
Environmental co-factors in HPV carcinogenesis.Virus Res. 2002 Nov;89(2):191-9. doi: 10.1016/s0168-1702(02)00188-0. Virus Res. 2002. PMID: 12445659 Review.
Cited by
-
Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.Hum Vaccin Immunother. 2014;10(7):1812-21. doi: 10.4161/hv.28742. Hum Vaccin Immunother. 2014. PMID: 25424787 Free PMC article. Review.
-
Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area.Infect Agent Cancer. 2015 Dec 8;10:44. doi: 10.1186/s13027-015-0040-y. eCollection 2015. Infect Agent Cancer. 2015. PMID: 26664495 Free PMC article.
-
Cervical cancer in Morocco: a literature review on risk factors, prevalence, and healthcare challenges.Pan Afr Med J. 2025 Jan 7;50:11. doi: 10.11604/pamj.2025.50.11.43975. eCollection 2025. Pan Afr Med J. 2025. PMID: 40290320 Free PMC article. Review.
-
High-Risk HPVs and Human Carcinomas in the Syrian Population.Front Oncol. 2014 Apr 2;4:68. doi: 10.3389/fonc.2014.00068. eCollection 2014. Front Oncol. 2014. PMID: 24765613 Free PMC article. Review.
-
Healthcare resource utilization and costs associated with anogenital warts in Morocco.Infect Agent Cancer. 2021 Nov 14;16(1):64. doi: 10.1186/s13027-021-00403-1. Infect Agent Cancer. 2021. PMID: 34775980 Free PMC article.